A Study of Evacetrapib (LY2484595) in Combination With Atorvastatin in Japanese Participants With Primary Hypercholesterolemia
A phase 3 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 149 participants.
Also called NCT02260648
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 149 participants
- Sponsor
- Registry
-
NCT02260648
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Japan
- Registry status
- Terminated
Technical summary
Registry record NCT02260648. Randomized; double masking; primary purpose treatment. Start 2015-01 (registry gives no type); primary completion 2015-11 (actual). Results posted on 2018-10-09.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study of Evacetrapib (LY2484595) in Combination With Atorvastatin in Japanese Participants With Primary Hypercholesterolemia
- Condition
- Hypercholesterolemia
- Intervention (Drug)
- Evacetrapib
- Intervention (Drug)
- Ezetimibe
- Intervention (Drug)
- Atorvastatin
- Intervention (Drug)
- Placebo
- Lead sponsor
- Eli Lilly and Company
Record details
- Record id
cardio:ct-nct02260648- Content hash
aa1aace1c46d8f54be4f7b3dd165bb29829d90a9c1e981102070916a06585162